Evidence map›Paper›PMID 38454524›Full record

ArticleStem cell research & therapy2024

PLOD2, a key factor for MRL MSC metabolism and chondroprotective properties.

Sarah Bahraoui, Gautier Tejedor, Anne-Laure Mausset-Bonnefont, François Autelitano, Audrey Barthelaix, Claudia Terraza-Aguirre, Vincent Gisbert, Yoan Arribat, Christian Jorgensen, Mingxing Wei and 1 more

Open access · goldAbstract read
In one paragraph

Article in Stem cell research & therapy, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 44% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Sarah BahraouiIRMB, University of Montpellier, INSERM U 1183, Hôpital Saint-Eloi, 80 Avenue Augustin Fliche, 34295, Montpellier cedex 5, France.
Gautier TejedorIRMB, University of Montpellier, INSERM U 1183, Hôpital Saint-Eloi, 80 Avenue Augustin Fliche, 34295, Montpellier cedex 5, France.
Anne-Laure Mausset-BonnefontIRMB, University of Montpellier, INSERM U 1183, Hôpital Saint-Eloi, 80 Avenue Augustin Fliche, 34295, Montpellier cedex 5, France.
François AutelitanoEVOTEC (France) SAS, 31100, Toulouse, France.
Audrey BarthelaixIRMB, University of Montpellier, INSERM U 1183, Hôpital Saint-Eloi, 80 Avenue Augustin Fliche, 34295, Montpellier cedex 5, France.
Claudia Terraza-AguirreIRMB, University of Montpellier, INSERM U 1183, Hôpital Saint-Eloi, 80 Avenue Augustin Fliche, 34295, Montpellier cedex 5, France.
Vincent GisbertIRMB, University of Montpellier, INSERM U 1183, Hôpital Saint-Eloi, 80 Avenue Augustin Fliche, 34295, Montpellier cedex 5, France.
Yoan ArribatIRMB, University of Montpellier, INSERM U 1183, Hôpital Saint-Eloi, 80 Avenue Augustin Fliche, 34295, Montpellier cedex 5, France.
Christian JorgensenIRMB, University of Montpellier, INSERM U 1183, Hôpital Saint-Eloi, 80 Avenue Augustin Fliche, 34295, Montpellier cedex 5, France.
Mingxing WeiCellVax, Villejuif Bio Park, 1 Mail du Professeur Georges Mathé, 94800, Villejuif, France.
Farida DjouadIRMB, University of Montpellier, INSERM U 1183, Hôpital Saint-Eloi, 80 Avenue Augustin Fliche, 34295, Montpellier cedex 5, France. farida.djouad@inserm.fr.ORCID 0000-0001-8248-6822
Inserm · FRLaboratoire d'études sur les monothéismes · FR

Funding

Agence Nationale de la Recherche ANR-20-CE18-0014
6 · The paper itself

Abstract

backgroundInitially discovered for its ability to regenerate ear holes, the Murphy Roth Large (MRL) mouse has been the subject of multiple research studies aimed at evaluating its ability to regenerate other body tissues and at deciphering the mechanisms underlying it. These enhanced abilities to regenerate, retained during adulthood, protect the MRL mouse from degenerative diseases such as osteoarthritis (OA). Here, we hypothesized that mesenchymal stromal/stem cells (MSC) derived from the regenerative MRL mouse could be involved in their regenerative potential through the release of pro-regenerative mediators.

methodTo address this hypothesis, we compared the secretome of MRL and BL6 MSC and identified several candidate molecules expressed at significantly higher levels by MRL MSC than by BL6 MSC. We selected one candidate, Plod2, and performed functional in vitro assays to evaluate its role on MRL MSC properties including metabolic profile, migration, and chondroprotective effects. To assess its contribution to MRL protection against OA, we used an experimental model for osteoarthritis induced by collagenase (CiOA).

resultsAmong the candidate molecules highly expressed by MRL MSC, we focused our attention on procollagen-lysine,2-oxoglutarate 5-dioxygenase 2 (PLOD2). Plod2 silencing induced a decrease in the glycolytic function of MRL MSC, resulting in the alteration of their migratory and chondroprotective abilities in vitro. In vivo, we showed that Plod2 silencing in MRL MSC significantly impaired their capacity to protect mouse from developing OA.

conclusionOur results demonstrate that the chondroprotective and therapeutic properties of MRL MSC in the CiOA experimental model are in part mediated by PLOD2.

Indexed as

Mesenchymal Stem CellsOsteoarthritisAnimalsMiceProcollagen-Lysine, 2-Oxoglutarate 5-Dioxygenaselysyl hydroxylase 2, mouseProcollagen-Lysine, 2-Oxoglutarate 5-DioxygenaseChondroprotectionMesenchymal stem cellsMetabolismMRL mousePLOD2Regeneration

Identifiers

PMID38454524
PMCPMC10921602
OpenAlexW4392549822

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.